Download abstracts, papers and presentations (all in pdf).

• Business as a partner – Engagement Models of the Global Fund, by David Hayward Evans, Corporate Partnerships Manager, The Global Fund to Fight AIDS, Tuberculosis and Malaria
• Governance of R & D for neglected diseases, by Chris Hentschel, President and Chief Executive Officer, Medicines for Malaria Venture (MMV)
• Why and how does the private sector invest in global health?, by Andreas Holzer, Bank Sarasin, Sustainable Investments
• Avoiding pouring money down the rathole, Donald G. McNeil Jr., Science Journalist, The New York
• Orientation in self-governing systems – a heuristic approach, by Vincent Paul Menken, Member of the Board Office, and Executive Assistant to the Management Board and the Chairman of Board of Trustees, Bertelsmann Foundation
• Partnerships needed to achieve the health related Millennium Development Goals (MDGs) – Keynote speech, by Pascoal Mocumbi, Haut Représentant, European and Developign Countries Clinical Trials Partnership (EDCTP), former Prime Minister of Mozambique
• The Global Fund as an example of self-governance in the public health sector, by Enrico Mollica, Director Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria, Geneva
• Changing Perspectives on Global Health Philanthropy: Governance Challenges, by Guy Pfeffermann, CEO and Chairman of the Board of the Management Education & Research Consortium, and former Director of the Global Business School Network of the International Finance Corporation
• Foundations as Catalysts for Health-Related Projects, by Stephen Robinson, DPhil., General Manager, Novo Nordisk Haemophilia Foundation

• Changing Perspectives on Global Health Philanthropy: Governance Challenges, by Guy Pfeffermann, CEO and Chairman of the Board of the Management Education & Research Consortium, and former Director of the Global Business School Network of the International Finance Corporation
• Avoiding pouring money down the rathole, by Donald G. McNeil Jr., Science Journalist, The New York Times

Opening Plenary

• Partnerships to achieve UN Millennium Goals, by Dr Pascoal Mocumbi, Haut Représentant, European and Developing Countries Clinical Trials Partnership (EDCTP), former Prime Minister of Mozambique
• Creative Philanthropy: Towards a new philanthropy in the 21st century, by Prof Helmut K Anheier, Professor of Sociology at Heidelberg University, Germany; Director of the Center for Civil Society, University of California

Plenary 1: The changing paradigms of global health

• Changing Perspectives on Global Health Philanthropy: Governance Challenges, by Dr Guy Pfeffermann, CEO and Chairman of the Board of the Management Education & Research Consortium, and former Director of the Global Business School Network of the International Finance Corporation
• Why and how does the private sector invest in global health ?, by Andreas Holzer, Sustainability Research, Bank Sarasin

Plenary 2:  Effectiveness of philanthropy

• Business as a partner – engaging models of the Global Fund, by David Hayward Evans, Corporate Partnerships Manager, the Global Fund
• Business comes on board, by Dr Robin Donnelly, Vice President Shell Health, Royal Dutch/Shell Group
• Foundations as catalysts for health-related projects, by Dr Stephen Robinson, General Manager, Novo Nordisk Haemophilia Foundation

Workshop 1:  Transparency, legitimacy and accountability of private initiatives

• Philanthropy in global health: governance and effectiveness criteria, by Dr Malebona Matsoso, Director Public Health Innovation and Intellectual Property, Office of the Director General, WHO
• Transparency, accountability and legitimacy of private initiatives, by PD Dr Kaspar Wyss, Project Leader, Swiss Tropical Institute
• Coartem - Saving precious lives, by Silvio Gabriel, Executive Vice President, Head of Malaria Initiatives, Novartis Pharma AG

Workshop 2:  Governance of R&D for neglected diseases

• Governance of R&D for neglected diseases, by Dr Chris Hentschel, President and Chief Executive Officer, Medicines for Malaria Venture (MMV)
• Better medicines for childeren: a global continuous challenge, by Dr Klaus Rose, Head Pediatrics, Hoffmann-La Roche
• WORKSHOP 2 REPORT, by Prof Marcel Tanner, Chairman of the Board of DNDi (Drugs for Neglected Diseases initiative)

The way forward - examples of self-governance

• The Global Fund as an example of self-governance in the public health sector, by Enrico Mollica, Director Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria, Geneva
• Orientation in self-governing systems - a heuristic approach, by Vincent Paul Menken, Executive Assistant to the Management Board, Bertelsmann Stiftung
• Assuring humanitarian accountability and quality, by Radha Dawn Ivory, Basel Institute on Governance, speaking on behalf of the Humanitarian Accountability Partnership-International (HAP-I)